the Medicaid and NC Health Choice programs cover ephedrine hydrochloride injection, for intravenous use
Topics Related to Physicians, Physician Assistants and Nurse Practitioners
the Medicaid and NC Health Choice programs cover filgrastim-ayow injection, for subcutaneous or intravenous use
Medicaid and NC Health Choice programs cover nivolumab and relatlimab-rmbw injection
Medicaid and NC Health Choice programs cover difelikefalin injection, for intravenous use
Medicaid and NC Health Choice programs cover sutimlimab-jome injection, for intravenous use
Effective with date of service March 15, 2022, the Medicaid and NC Health Choice programs cover naloxone hydrochloride injection for intramuscular or subcutaneous use.
Effective with date of service March 2, 2022, the Medicaid and NC Health Choice programs cover plasminogen, human-tvmh lyophilized powder for reconstitution.
Effective with date of service March 29, 2022, the Medicaid and NC Health Choice programs cover hepatitis b vaccine (recombinant) injectable suspension.
Effective with date of service Feb. 25, 2022, the Medicaid and NC Health Choice programs cover tebentafusp-tebn injection.
Effective with date of service Feb. 23, 2022, the Medicaid and NC Health Choice programs cover sirolimus protein-bound particles for injectable suspension (albumin-bound).